These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 15120668)

  • 21. Novel CDKN2A mutations detected in western Swedish families with hereditary malignant melanoma.
    Erlandson A; Appelqvist F; Wennberg AM; Holm J; Enerbäck C
    J Invest Dermatol; 2007 Jun; 127(6):1465-7. PubMed ID: 17255954
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uptake of genetic counseling, genetic testing and surveillance in hereditary malignant melanoma (CDKN2A) in Norway.
    Levin T; Mæhle L
    Fam Cancer; 2017 Apr; 16(2):257-265. PubMed ID: 27804060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation screening of the CDKN2A promoter in melanoma families.
    Harland M; Holland EA; Ghiorzo P; Mantelli M; Bianchi-Scarrà G; Goldstein AM; Tucker MA; Ponder BA; Mann GJ; Bishop DT; Newton Bishop J
    Genes Chromosomes Cancer; 2000 May; 28(1):45-57. PubMed ID: 10738302
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical applications of melanoma genetics.
    Gabree M; Patel D; Rodgers L
    Curr Treat Options Oncol; 2014 Jun; 15(2):336-50. PubMed ID: 24652319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MC1R variants increase melanoma risk in families with CDKN2A mutations: a meta-analysis.
    Fargnoli MC; Gandini S; Peris K; Maisonneuve P; Raimondi S
    Eur J Cancer; 2010 May; 46(8):1413-20. PubMed ID: 20189796
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased melanocytic nevi and nevus density in a G-34T CDKN2A/p16 melanoma-prone pedigree.
    Florell SR; Meyer LJ; Boucher KM; Grossman D; Cannon-Albright LA; Harris RM; Samlowski WE; Zone JJ; Leachman SA
    J Invest Dermatol; 2008 Aug; 128(8):2122-5. PubMed ID: 18337833
    [No Abstract]   [Full Text] [Related]  

  • 27. Role of the cyclin-dependent kinase inhibitor CDKN2A in familial melanoma.
    Hogg D; Brill H; Liu L; Monzon J; Summers A; From L; Lassam NJ
    J Cutan Med Surg; 1998 Jan; 2(3):172-9. PubMed ID: 9479083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Recommendations for genetic testing and management of individuals genetically at-risk of cutaneous melanoma].
    Avril MF; Bahadoran P; Cabaret O; Caron O; de la Fouchardière A; Demenais F; Desjardins L; Frébourg T; Hammel P; Leccia MT; Lesueur F; Mahé E; Martin L; Maubec E; Remenieras A; Richard S; Robert C; Soufir N; Stoppa-Lyonnet D; Thomas L; Vabres P; Bressac-de Paillerets B
    Ann Dermatol Venereol; 2015 Jan; 142(1):26-36. PubMed ID: 25600792
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetics of melanoma predisposition.
    Lin J; Hocker TL; Singh M; Tsao H
    Br J Dermatol; 2008 Aug; 159(2):286-91. PubMed ID: 18547303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic testing in hereditary melanoma.
    Tsao H; Niendorf K
    J Am Acad Dermatol; 2004 Nov; 51(5):803-8. PubMed ID: 15523363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic testing for melanoma predisposition: current challenges.
    Gerstenblith MR; Goldstein AM; Tucker MA; Fraser MC
    Cancer Nurs; 2007; 30(6):452-9; quiz 462-3. PubMed ID: 18025917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Melanoma susceptibility genes and risk assessment.
    Marzuka-Alcalá A; Gabree MJ; Tsao H
    Methods Mol Biol; 2014; 1102():381-93. PubMed ID: 24258989
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of genetic factors for melanoma susceptibility in sporadic US melanoma patients.
    Council ML; Gardner JM; Helms C; Liu Y; Cornelius LA; Bowcock AM
    Exp Dermatol; 2009 May; 18(5):485-7. PubMed ID: 19320745
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CDKN2A mutations and MC1R variants in Italian patients with single or multiple primary melanoma.
    Pastorino L; Bonelli L; Ghiorzo P; Queirolo P; Battistuzzi L; Balleari E; Nasti S; Gargiulo S; Gliori S; Savoia P; Abate Osella S; Bernengo MG; Bianchi Scarrà G
    Pigment Cell Melanoma Res; 2008 Dec; 21(6):700-9. PubMed ID: 18983535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Germline mutations of the INK4a-ARF gene in patients with suspected genetic predisposition to melanoma.
    Soufir N; Lacapere JJ; Bertrand G; Matichard E; Meziani R; Mirebeau D; Descamps V; Gérard B; Archimbaud A; Ollivaud L; Bouscarat F; Baccard M; Lanternier G; Saïag P; Lebbé C; Basset-Seguin N; Crickx B; Cave H; Grandchamp B
    Br J Cancer; 2004 Jan; 90(2):503-9. PubMed ID: 14735200
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Alterations in CDKN2A locus as potential indicator of melanoma predisposition in relatives of non-familial melanoma cases.
    Levanat S; Situm M; Crnić I; Marasović D; Puizina-Ivić N; Pokupcić N; Musani V; Komar A; Kubat M; Furac I; Karija-Vlahović M; Krizanac S
    Croat Med J; 2003 Aug; 44(4):418-24. PubMed ID: 12950144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel methionine-53-valine mutation of p16 in a hereditary melanoma kindred.
    Yang G; Niendorf KB; Tsao H
    J Invest Dermatol; 2004 Sep; 123(3):574-5. PubMed ID: 15304098
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CDKN2A/CDK4 molecular study on 155 Italian subjects with familial and/or primary multiple melanoma.
    Majore S; De Simone P; Crisi A; Eibenschutz L; Binni F; Antigoni I; De Bernardo C; Catricalà C; Grammatico P
    Pigment Cell Melanoma Res; 2008 Apr; 21(2):209-11. PubMed ID: 18363633
    [No Abstract]   [Full Text] [Related]  

  • 39. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families.
    Mantelli M; Barile M; Ciotti P; Ghiorzo P; Lantieri F; Pastorino L; Catricalà C; Torre GD; Folco U; Grammatico P; Padovani L; Pasini B; Rovini D; Queirolo P; Rainero ML; Santi PL; Sertoli RM; Goldstein AM; Bianchi-Scarrà G; ;
    Am J Med Genet; 2002 Jan; 107(3):214-21. PubMed ID: 11807902
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Germline CDKN2A mutations in childhood melanoma: a case of melanoma-pancreatic cancer syndrome.
    Gironi LC; Colombo E; Farinelli P; Giorgione R; Bozzola C; Ogliara P; Pasini B
    Int J Dermatol; 2015 Dec; 54(12):e553-5. PubMed ID: 26381259
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.